Icon

AUSTEDO (nda208082)- (6MG,9MG,12MG)

DEUTETRABENAZINE TEVA BRANDED PHARM
6MG,9MG,12MG
Yes Yes
2038-Sep-15 2022-Apr-03
2024-Apr-03 None
None No
AUSTEDO is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia in adults
0 1 0
Total Other Developers 12
Drugs with Suitability No
6MG ** ** Up - -
9MG ** ** Up - -
12MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.